Clinical Marketing Associate Director (Provider Channel) #4424 at GRAIL

Menlo Park, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, OncologyIndustries

Requirements

Bachelor’s degree required; advanced degree strongly preferred (MS, MPH, PhD, PharmD, or MBA with strong scientific acumen)
10+ years total experience with 5+ years in HCP/clinical marketing or Medical Affairs roles within diagnostics, biotech, or medtech; oncology or primary care experience a plus
Demonstrated leadership of national congress portfolios, KOL/peer-to-peer programs, and clinical content development in a regulated environment
Deep familiarity with MLR processes and claims governance; experience with vendor management
Exceptional cross-functional leadership, communication, and stakeholder management
Proficiency with content management, CRM systems (e.g., Veeva PromoMats, Salesforce) and analytics tools (e.g., Tableau); webinar platforms
Hybrid role requiring onsite presence at least 2 days a week in Menlo Park, CA

Responsibilities

Establish and maintain expertise in relevant clinical data for the Galleri test; translate evidence into clear, balanced claims and messaging frameworks
Serve as a primary marketing liaison to the field medical team (MSLs) to align education priorities, publication pull-through, and KOL engagement
Own end-to-end medical conference strategy for marketing: annual portfolio plan, booth and symposia strategy, satellite events, abstracts/posters support with Medical Affairs, and pre/during/post-conference campaigns
Support the development of commercial KOL strategy to drive demand; map priority KOLs, manage speaker program in partnership with Med Affairs, advisory boards, and testimonials/case studies
Lead vendors and manage SOWs, timelines, and budget
Drive measurement and optimization of marketing programs; share insights for continual improvement

Skills

Clinical Marketing

HCP Marketing

KOL Engagement

Conference Planning

Content Development

Medical Affairs Collaboration

Peer-to-Peer Programs

Healthcare Provider Strategy

MCED Testing

Galleri Test

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$1,765.5MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.

Significant net losses may affect investor confidence and long-term sustainability.

High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.

The Galleri test screens for over 50 cancers with a single blood draw.

GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.

Revenue from Galleri grew 52% year-over-year, indicating strong market demand.

GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI

Try Jobo Free